A new article published in Nature Reviews Disease Primers underscores the profound role that stigma can play in health care — and how addressing stigma-related barriers can significantly improve health outcomes for individuals and communities around the world.
FDA approves Ipsen’s ultra-rare disease drug palovarotene
The FDA gave a nod of approval to Ipsen’s treatment for the ultra-rare disease fibrodysplasia ossificans progressiva though regulators have expressed concerns at least twice
August 17, 2023